4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0001209191-22-021449
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
PASSERI DANIEL R · CHIEF EXECUTIVE OFFICER
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-25 | Grant or award : show line 1 in the form Stock Option (right to buy) | +100,000 | 100,000 | D |
Loading xslF345X03/doc4.xml…